News.bms.com

News Bms. {{{body}}}' + , '' , ), , beforeRenderItems: function (e, tplData) { , var searchTerm = $('.module-search--news. module-search_input').val().trim().toLowerCase(); ...

Today's News.bms.com headlines: Observe fresh posts and updates on News Bms. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or News.bms.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to News Bms

Subscribe to related news

Bristol-Myers Squibb announced promising results from an expanded phase 1 dose-ranging study of its lung cancer drug niv...
via newdrugapprovals.wordpress

NIVOLUMAB Anti-PD-1;BMS-936558; ONO-4538 PRONUNCIATION nye vol’ ue mab THERAPEUTIC CLAIM Treatment of cancer CHEMICAL DESCRIPTION A fully human IgG4 antibody blocking the programmed cell death-1 receptor (Medarex/Ono Pharmaceuticals/Bristol...
BRIEF-Bristol-Myers’ Opdivo fails late-stage study in patients with lung cancer
via traderhub

* Bristol-Myers Squibb announces top-line results from checkmate -026, a phase 3 study of Opdivo (nivolumab) in treatment-naïve patients with advanced non-small cell lung cancer Reuters: Mergers News
STATE FOCUS: Florida – Let The Sun Shine
via businessfacilities

Southwest view of the Fort Lauderdale International Airport. (Photo: Greater Fort Lauderdale Alliance.) By Dominique Cantelme From the July/August 2013 issue It looks like Florida may see more than just the sun shining in the next four years. According...
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
via channelnewsasia

REUTERS: Recent clinical trial results are likely to lead doctors to treat more patients who have a common form of lung cancer with a Merck drug at the expense of a Bristol-Myers Squibb medication at least until more data emerges, oncologists and analysts...
Deals Of The Week Wonders Whether Heated Competition To Buy Ache Laboratorios Will Muddy The Brazilian Waters
via invivoblog.blogspot

Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories’ gargantuan purchase of part of India’s Piramal Healthcare did for biopharma M&A in India? Call it the “Piramal...

News.bms.com popular pages

Bristol Myers Squibb - News

{{{body}}}' + '' ), beforeRenderItems: function (e, tplData) { var searchTerm = $('.module-search--news .module-search_input').val().trim().toLowerCase(); ...
Bristol-Myers Squibb Completes Previously Announced Acquisition of Cardioxyl Pharmaceuticals, Inc. | BMS Newsroom

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has completed the previously announced planned acquisition of Cardioxyl Pharmaceuticals, Inc.

First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab) Regimen Demonstrates Superior Efficacy Versus Yervoy

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from a Phase II trial (CheckMate -069), evaluating the Opdivo (nivolumab)+Yervoy (ipilimumab)...